Grant of Share Options
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your EMVC notes
EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment group, announces that it has granted a total of 345,000 new options (New Options) to subscribe for ordinary shares in the capital of the Company (Ordinary Shares) to its directors and a PDMR, as detailed below.
In line with the Company's remuneration policy, the Remuneration Committee has approved the award of the following New Options to the Executive Directors and a PDMR as referred to below in connection with their annual remuneration. In addition, the Company's Board has approved the award of the following New Options to its Non-Executive Directors.
| Director | New Options | Total options held (including existing options) |
|---|---|---|
| Dr Ilian Iliev, CEO | 120,000 | 685,656 |
| Ed Hooper, Executive Director | 120,000 | 685,656 |
| Dr Charles Spicer, Chair | 30,000 | 125,238 |
| Dr Jonathan Robinson, Senior Independent Director | 30,000 | 99,610 |
| Nick Salisbury, PDMR | 45,000 | 45,000 |
The New Options were granted under the EMV Capital Share Option Scheme, pursuant to which options over a total of 2,417,732 Ordinary Shares have now been granted (excluding lapsed options but including exercised options), representing approximately 8.71 per cent. of the Company's issued share capital. The maximum potential dilution arising from options awarded under the EMV Capital Share Option Scheme remains below the upper limit of 10 per cent. under the rules of the plan.
The New Options have an exercise price of 50 pence per share, which price is equal to the issue price for the Company's recent share issuance (announced 5 December 2024) and higher than the average of the closing market quotations for Ordinary Shares over the five dealing days prior to the date on which the New Options were granted (the latter being the minimum price that could have been set).
The New Options will vest as to one third on the date of grant, as to a further third on the first anniversary of the date of grant and as to the final third on the second anniversary of the date of grant. The New Options may not be exercised earlier than the third anniversary of the date of grant and lapse 10 years after the date of grant (if not sooner in accordance with the terms of the EMV Capital Share Option Scheme rules).
The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation, is appended below.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr Ilian Iliev | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Director | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | EMV Capital plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
options | ||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||
| e) | Date of the transaction | 30 December 2024 | ||||
| f) | Place of the transaction | UK AIM | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Ed Hooper | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Director | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | EMV Capital plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
options | ||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||
| e) | Date of the transaction | 30 December 2024 | ||||
| f) | Place of the transaction | UK AIM | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr Charles Spicer | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Director | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | EMV Capital plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
options | ||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||
| e) | Date of the transaction | 30 December 2024 | ||||
| f) | Place of the transaction | UK AIM | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr Jonathan Robinson | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Director | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | EMV Capital plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
options | ||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||
| e) | Date of the transaction | 30 December 2024 | ||||
| f) | Place of the transaction | UK AIM | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Nick Salisbury | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | EMV Capital plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
options | ||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||
| e) | Date of the transaction | 30 December 2024 | ||||
| f) | Place of the transaction | UK AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.